Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 3/20 | 0.34 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 2/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31068605 | 0.88 | USP2 (0.38) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 | |
| SCHEMBL18309957 | 0.83 | USP2 (0.41) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 | |
| SCHEMBL29347021 | 0.83 | TGM2 (0.38) | USP2SMN1; SMN2CYP11B2USP30RORC | |
| SCHEMBL3494732 | 0.82 | USP2 (0.43) | USP2SMN1; SMN2OPRD1OPRK1NR1H2 | |
| SCHEMBL18418212 | 0.81 | USP2 (0.50) | USP2SMN1; SMN2OPRD1OPRK1NR1H2 | |
| SCHEMBL24854181 | 0.81 | USP2 (0.39) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 | |
| SCHEMBL30289446 | 0.81 | USP2 (0.42) | USP2SMN1; SMN2OPRD1OPRK1NR1H2 | |
| SCHEMBL31695027 | 0.81 | USP2 (0.39) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 | |
| SCHEMBL31695034 | 0.81 | USP2 (0.39) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 | |
| SCHEMBL17763768 | 0.80 | USP2 (0.40) | USP2SMN1; SMN2OPRD1OPRK1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650348-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | disclosed |
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | disclosed |